Integral Health Asset Management, LLC Charles River Laboratories International, Inc. Transaction History

Integral Health Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$164.52 - $238.84 $10.7 Million - $15.5 Million	65,000 New	65,000 $15.4 Million
Q2 2021 Aug 13, 2021	SELL	$294.17 - $371.65 $10.3 Million - $13 Million	-35,000 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$249.67 - $299.48 $4.49 Million - $5.39 Million	-18,000 Reduced 33.96%	35,000 $10.1 Million
Q4 2020 Feb 16, 2021	BUY	$222.0 - $252.62 $4.44 Million - $5.05 Million	20,000 Added 60.61%	53,000 $13.2 Million
Q3 2020 Nov 16, 2020	SELL	$175.56 - $226.45 $3.86 Million - $4.98 Million	-22,000 Reduced 40.0%	33,000 $7.47 Million
Q2 2020 Aug 14, 2020	BUY	$118.84 - $189.72 $6.54 Million - $10.4 Million	55,000 New	55,000 $9.59 Million

692

52M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.32B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.